Bandingkan Harga & Kinerja Kimia Farma Tbk (KAEF) vs Reksa Dana Indeks SAM ETF SRI-KEHATI (XSSK)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kimia Farma Tbk dan Reksa Dana Indeks SAM ETF SRI-KEHATI: Kimia Farma Tbk diperdagangkan di Rp454 (kapitalisasi pasar 2,53 T, volume 24 jam 524 rb), sedangkan Reksa Dana Indeks SAM ETF SRI-KEHATI diperdagangkan di Rp666 (kapitalisasi pasar 11,92 M). Perbedaan utamanya: Kimia Farma Tbk jauh lebih besar — sekitar 212,2× kapitalisasi pasar Reksa Dana Indeks SAM ETF SRI-KEHATI. Mana yang lebih baik tergantung tujuan investasimu.
| KAEF | XSSK | |
|---|---|---|
Kapitalisasi Pasar | 2,53 T | 11,92 M |
Volume | 524 rb | — |
Lot | 5,24 rb | — |
Perputaran | 236,25 jt | — |
Harga Rata-rata | 450,87 | — |
Nilai Transaksi | 236,25 jt | — |
Harga Ekuilibrium Indikatif | 454 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kimia Farma Tbk
PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Selengkapnya di halaman KAEF →
